Abstract
The earliest activity-based photoacoustic (PA) probes were developed as diagnostic agents for cancer. Since this seminal work over a decade ago that specifically targeted matrix metalloproteinase-2, PA instrumentation, dye platforms, and probe designs have advanced considerably, allowing for the detection of an impressive list of cancer types. However, beyond imaging for oncology purposes, the ability to selectively visualize a given disease biomarker, which can range from aberrant enzymatic activity to the overproduction of reactive small molecules, is also being exploited to study a myriad of noncancerous disease states. In this review, we have assembled a collection of recent papers to highlight the design principles that enable activity-based sensing via PA imaging with respect to biomarker identification and strategies to trigger probe activation under specific conditions.
Original language | English (US) |
---|---|
Pages (from-to) | 223-232 |
Number of pages | 10 |
Journal | ACS Bio and Med Chem Au |
Volume | 3 |
Issue number | 3 |
Early online date | Mar 10 2023 |
DOIs | |
State | Published - Jun 21 2023 |
Keywords
- activatable probes
- activity-based sensing
- biomarkers
- biomedical imaging
- human diseases
- in vivo
- molecular imaging
- optoacoustic
- photoacoustic
- preclinical
ASJC Scopus subject areas
- Drug Discovery
- Molecular Biology
- Biochemistry
- Pharmaceutical Science